“Biosimilars: To Switch or Not to Switch?” will be the focus of this year’s Great Debate at the 2017 ACR/ARHP Annual Meeting in San Diego. The debate is scheduled for 2:30 p.m. on Nov. 5 and will feature the perspectives of Dr. Jonathan Kay...
6-Sep-2017 2:05 PM EDT Add to Favorites
NFL Hall of Famer Terry Bradshaw Teams Up with the American College of Rheumatology to Tackle Rheumatic Disease this September
The American College of Rheumatology (ACR) and its public awareness campaign, Simple Tasks™, are teaming up with former NFL quarterback Terry Bradshaw to raise awareness about this growing and costly healthcare crisis during September’s...
29-Aug-2017 7:00 AM EDT Add to Favorites
“Expanding our patients’ access to safe, effective, and affordable biologic and biosimilar therapies is a top priority of the rheumatology community. Therefore, the American College of Rheumatology applauds new legislative and regulatory...
25-Aug-2017 10:05 AM EDT Add to Favorites
The joint guideline between ACR and AAHKS provides eight recommendations on preoperative management of total hip and knee replacements.
16-Jun-2017 1:05 PM EDT Add to Favorites
Health leaders today announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.
13-Jun-2017 2:05 PM EDT Add to Favorites
ACR Releases Updated Clinical Guideline for the Prevention & Treatment of Glucocorticoid-Induced Osteoporosis
The American College of Rheumatology’s (ACR) updated clinical guideline for the prevention and treatment of Glucocorticoid-Induced Osteoporosis is now available online. The guideline provides recommendations on assessing fracture risk and...
7-Jun-2017 10:05 AM EDT Add to Favorites
The American College of Rheumatology (ACR) today expressed opposition to the Trump Administration’s proposed budget cuts to federal programs and institutions that provide critical resources in the fight against rheumatic diseases, including the...
23-May-2017 5:05 PM EDT Add to Favorites
Today, the American College of Rheumatology submitted comments to the U.S. Food and Drug Administration concerning the draft guidance, ‘Considerations in Demonstrating Interchangeability with a Reference Product’ (FDA 2017-01042).’
19-May-2017 3:05 PM EDT Add to Favorites
25-Jun-2012 10:55 AM EDT